1M
IRWD icon

13D Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

13D Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-419,284
Closed -$3.65M – 29
2024
Q1 		$3.65M Buy
419,284
+51,635
+14% +$627K 2.23% 27
2023
Q4 		$4.21M Buy
367,649
+333,348
+972% +$3.3M 2.47% 28
2023
Q3 		$330K Sell
34,301
-476,806
-93% -$4.67M 0.21% 27
2023
Q2 		$5.44M Sell
511,107
-22,455
-4% -$241K 2.97% 16
2023
Q1 		$5.61M Hold
533,562
– – 2.85% 19
2022
Q4 		$6.61M Sell
533,562
-66,869
-11% -$759K 3.48% 11
2022
Q3 		$6.22M Hold
600,431
– – 3.25% 13
2022
Q2 		$6.92M Buy
600,431
+37,328
+7% +$440K 3.06% 18
2022
Q1 		$7.08M Sell
563,103
-49,750
-8% -$570K 2.69% 19
2021
Q4 		$7.15M Sell
612,853
-37,602
-6% -$461K 2.74% 21
2021
Q3 		$8.49M Hold
650,455
– – 3.16% 17
2021
Q2 		$8.37M Sell
650,455
-7,562
-1% -$86.6K 2.88% 21
2021
Q1 		$7.36M Buy
658,017
+287,582
+78% +$3.04M 2.73% 24
2020
Q4 		$4.22M Sell
370,435
-65,887
-15% -$721K 1.74% 28
2020
Q3 		$3.92M Buy
436,322
+5,678
+1% +$56.4K 1.73% 26
2020
Q2 		$4.44M Sell
430,644
-17,324
-4% -$177K 1.93% 25
2020
Q1 		$4.52M Buy
447,968
+27,215
+6% +$320K 2.2% 23
2019
Q4 		$5.6M Sell
420,753
-92,162
-18% -$1.02M 1.7% 25
2019
Q3 		$4.4M Buy
512,915
+23,385
+5% +$227K 1.45% 21
2019
Q2 		$5.36M Buy
+489,530
New +$5.48M 1.61% 25

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

13D Management's IRWD Position: Q2 2024 in Review

13D Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 419,284 shares — an estimated $3.65M sold.

13D Management first reported a position in IRWD in Q2 2019 and held it in 20 quarters. The position peaked at $8.49M in Q3 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • 13D Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • 13D Management sold 419,284 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $3.65M.
  • 13D Management first reported a position in Ironwood Pharmaceuticals in Q2 2019 and held it in 20 quarters.
  • 13D Management's Ironwood Pharmaceuticals position peaked at $8.49M in Q3 2021.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on 13D Management's 13F filing for Q2 2024, filed 14 Aug 2024.